Current Roles

Employees:
31
Revenue:
$3.5M
About
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.
Cognetivity Neurosciences Ltd Address
2 Royal College Street
London, null
UK
Cognetivity Neurosciences Ltd Email